Summary: Using monoclonal antibodies instead of conventional immunosuppressant drugs preserves stem cells in mouse brains.

Source: University of Michigan.

A new approach to stem cell therapy that uses antibodies instead of traditional immunosuppressant drugs robustly preserves cells in mouse brains and has potential to fast-track trials in humans, a Michigan Medicine study suggests.